Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03955250 · ClinicalTrials.gov registry record · NA
Mobile After-Care Support App: Pilot RCT
A NA study of Psychotic Disorder, sponsored by Butler Hospital.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT03955250: Completed NA study of Psychotic Disorder, sponsored by Butler Hospital.
NCT03955250 is a NA study of Psychotic Disorder that has completed, run by Butler Hospital. The registered enrollment target is 42 participants, below the 335-participant average among 5 other Psychotic Disorder trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03955250, a NA study of Psychotic Disorder, has completed, sponsored by Butler Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall aim of this program of research is to refine and test the feasibility and acceptability of a newly developed mobile device-delivered app, called Mobile After-Care Support (MACS), to improve patients' coping and treatment adherence following a hospitalization related to their psychotic-spectrum disorder. The purpose of the proposed project is to establish the feasibility, acceptability, and preliminary effects of the app. To achieve the specific aims, the investigators will conduct a pilot randomized clinical trial (n = 60), with two treatment arms: MACS vs. a mobile app attention control condition.
Primary Outcome
The Client Satisfaction Questionnaire is a self-report measure of patient satisfaction with treatment. The total score (sum of items) will be used and ranges from 8 to 32 with increased scores indicating greater satisfaction with treatment.
Conditions Studied
Interventions
- BEHAVIORAL Mobile After-Care Support (MACS) app
- BEHAVIORAL Mobile app attention control
Study Locations (1)
Rhode Island
- Butler Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2019-05-31 |
| Est. Completion | 2022-05-31 |
| Phase | NA |
What the finished NCT03955250 record still lists
NCT03955250 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 335-participant average among 5 other Psychotic Disorder trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Psychotic Disorder appearing as the primary indexed condition, and to 2 interventions - of which Mobile After-Care Support (MACS) app is the first listed.
NCT03955250 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT03955250 about?
NCT03955250 is a clinical study titled "Mobile After-Care Support App: Pilot RCT". The overall aim of this program of research is to refine and test the feasibility and acceptability of a newly developed mobile device-delivered app, called Mobile After-Care Support (MACS), to improve patients' coping and treatment adherence following a hospitalization related to their psychotic-sp...
What is the current status of trial NCT03955250?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2019-05-31. Estimated completion is 2022-05-31.
What conditions does trial NCT03955250 study?
This clinical trial studies the following conditions: Psychotic Disorder.
What interventions are being tested in trial NCT03955250?
The interventions under investigation include: Mobile After-Care Support (MACS) app (BEHAVIORAL), Mobile app attention control (BEHAVIORAL).
Who is sponsoring clinical trial NCT03955250?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03955250 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Psychotic Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Brain Stimulation to the Hippocampus in Schizophrenia
RECRUITING · NA
-
Changing Lives and Changing Outcomes-9 at Worcester Recovery Center and Hospital
RECRUITING · NA
-
Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy
RECRUITING · NA
-
Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)
COMPLETED · NA
-
Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI